Home About Us Contact Us

 

Table of Content - Volume 18 Issue 3 - June 2021


 

The Study of oxidant and antioxidant status with special emphasis to homocysteine, total protein and albumin in nephrotic syndrome

 

G Prem Kumar1, Vellanki Lakshmi Narasamma2*, K Satya Sri3

 

{1Associate Professor, Department of Biochemistry} {3Associate Professor, Department of Pathology} Andhra Medical College, Visakhapatnam, INDIA.

2Associate Professor, Department of Biochemistry, Government General Hospital, Srikakulam, INDIA.

Email: lifesresearch9@gmail.com

 

Abstract              Background: Nephrotic patients show various abnormalities in protein kinetics. Plasma albumin levels and the total plasma albumin pool are reduced. Nephrotic syndrome is a consequence of an imbalance between oxidant and anti-oxidant activity. Oxidative damage has been proposed as one of the possible mechanism involved in the Nephrotic syndrome. Therefore, this study was carried out to investigate oxidant and antioxidant status with Homocysteine in Nephrotic syndrome patients. The blood samples were analyzed for quantitation of total protein, albumin, Malondialdehyde as index of lipid peroxide, vitamin C, total antioxidant capacity and Homocysteine. Significantly increased levels of serum lipid peroxide, Homocysteine and decreased levels total protein, albumin, serum total antioxidant capacity and plasma vitamin C were noticed in the patients with Nephrotic syndrome as compared to control subjects. However, significant positive correlation in lipid peroxide with Homocysteine and total protein with total antioxidant capacity, were observed in the patients of Nephrotic syndrome with age group among 30-80 years.

Keywords: Nephrotic syndrome, Total antioxidant capacity, Homocysteine, Malondialdehyde, Vitamin C.

 

INTRODUCTION

Nephrotic syndrome (NS) is caused by increased permeability of the glomerular capillary wall for proteins1. Nephrotic syndrome is the common chronic disorder characterized by alteration of permeability of the glomerular capillary wall, resulting in its inability to restrict the urinary loss of proteins2. Nephrotic syndrome is a stressful condition for children where oxidative damage would also influence the response of these patients to therapy3. The production of free radicals can cause renal injury and play an important role in the pathogenesis of Nephrotic syndrome 4. Excessive generation of reactive oxygen species is one of the incriminated mechanisms in the pathogenesis of progressive renal injury. The role of oxidant stress in acute and chronic glomerular diseases has been investigated through experimental and clinical studies5. Nephrotic syndrome is characterized by heavy proteinuria and hypoalbuminemia. Reactive oxygen species (ROS) seem to play an important role in the etiopathogenesis of proteinuria in NS. The potential role of reactive oxygen species in pathogenesis of NS by estimating the levels of oxidants and antioxidants in NS6. The atherothrombotic risk pattern of the Nephrotic syndrome resembles that of Hyperhomocysteinemia7. Proteinuria and Hyperhomocysteinaemia are independently associated with increased risk of atherosclerosis and cardiovascular disease8. Changes in metabolism of aminothiols may have an influence on endothelial function or change the red-ox balance9. Various biochemical parameters that are presently determined in serum/plasma Homocysteine, total antioxidant capacity, lipid peroxidation, Vit C, total protein, albumin for the diagnosis of Nephrotic syndrome, as well as to determine the oxidative stress on the basis of above parameters in NS. The Purpose of this research is to estimate different biochemical parameters in patients of Nephrotic syndrome and to determine the Interrelationship of Homocysteine, oxidant and antioxidant status in Nephrotic syndrome.

 

MATERIALS AND METHODS

The present study was conducted at the Department of Biochemistry, Government General Hospital, Srikakulam with collaboration of Department of Biochemistry, Andhra Medical College, Visakhapatnam. The present study was conducted on 2 groups: group I comprised of 135 controls, group II comprised of 133 Nephrotic syndrome patients in the age group of 30-80 years. The patients were diagnosed on the basis of detailed clinical history, clinical examination and other relevant biochemical investigations. The patients suffering from other diseases, such as diabetes, inflammatory diseases, cardiac diseases, hepatic impairment, and respiratory diseases or other systemic diseases as well as smokers and alcoholics, were excluded from the study. Informed consent was obtained from each participant in the study. Fasting venous blood were drawn from all. Total Protein and Albumin were estimated by a commercially available kit from “ERBA” in semiautomatic auto analyzer. Total antioxidant capacity (TAC) in serum was estimated by using spectrophotometric method Koracevic et al.10. MDA, one of the aldehydic by product of lipid peroxidation in serum, was estimated by its thiobarbituric acid reactivity using, spectrophotometric method Hunter et al.11. Plasma ascorbic acid (Vit C) was measured by colorimetric method Roe and Kuether et al.12. Homocysteine was estimated by commercial “LS BIO diagnostic kit” using  Bio-Rad ELISA reader. The values were expressed as mean +/- SD. Student test was done for comparison of data. The laboratory investigations were performed on groups I and II.


 

Table 1: Comparison of biochemical parameters in group I and group II

Parameters

Group I (controls)

(Mean ± SD) N=135

Group II (Nephrotic Syndrome Cases) (Mean ± SD) N=133

Significance

Total

protein(g/dL)

6.80 ± 1.6

3.26 ± 3.3

p<0.001

Albumin (g/dL)

4.14 ± 0.37

1.37 ± 0.70

p<0.001

Total Antioxidant

Capacity (mmol/L)

2.37 ± 0.87

1.55 ± 0.28

p<0.0001

Malondialdehyde

(nmol/mL)

1.56 ± 0.96

3.58 ± 0.42

p<0.001

Homocysteine

(umol/L)

10.75 ± 3.1

17.77 ± 4.15

p<0.001

Vit C (mg/dL)

1.48 ± 0.65

0.68 ± 0.48

p<0.0001

 

Table 2: Correlation coefficient of different parameters in group II patients

Parameters

Correlation coefficient (r)

Significance

HCY and MDA

+0.78

p<0.001

Alb and HCY

-0.40

p<0.05

TP and HCY

-0.46

p<0.05

HCY and TAC

-0.25

p<0.0001

TP and MDA

-0.55

P<0.001

HCY-Homocysteine, MDA-Malondialdehyde, Alb-Albumin, TP-Total protein, TAC-Total antioxidant capacity.

 


DISCUSSION

The Nephrotic syndrome is characterized by increased urinary excretion of albumin and other serum proteins, accompanied by hypoproteinemia and edema formation13. The molecular mechanisms behind acquired NS are still largely unknown. One possible explanation for the development of proteinuria is oxidative damage to the glomerular cells14. Albumin has also emerged as a major plasma antioxidant, and recent studies have demonstrated that in patients with active focal segmental glomerulosclerosis albumin undergoes massive and stable oxidation with sulfonation of Cys34, formation of an adduct with +48 Da molecular weight, changes of the net charge due to additional negative residues, and loss of free thiol group (SH) titration. Altogether, these data suggest that oxidative stress determines selective protein damages in focal segmental glomerulosclerosis patients with formation of new adducts and fragmentation of plasma proteins. Research should now address whether oxidation of podocyte proteins is important for the maintenance of renal selectivity and is involved in proteinuria15. Reactive oxygen species (ROS) are reported to play a role in inducing the proteinuria of NS16. Albumin is a potent antioxidant as it chelates transitional metals and contains antioxidants like thiol and bilirubin17. In the present study increased Homocysteine level is related to endothelial dysfunction, some other study is in agreement with this concept Majumdar et al.18 that Homocysteine mediated impairment of endothelial dependent vasodilation were reversed by incubating Homocysteine with nicotinamide (an inhibitor of peroxinitrate and nitrotyrosine) suggests a role of Homocysteine in redox mediating endothelial dysfunction and nitrotyrosine formation, this is supported to oxidative stress and endothelial dysfunction by Homocysteine. These findings are in agreement with the findings of Gurusharan et al. [19]where Homocysteine was significantly correlated with serum creatinine (r=0.58; p<0.01) and calculated GFR (R=-0.45; p<0.05). Increased Homocysteine level is due to renal failure for effective amino acids clearance. However, Margret et al. [20]showed significantly lower Homocysteine level in NS patients than non NS patients. Disturbances in oxidant and antioxidant status were observed by many other studies, which was in agreement of our study Warwick et al.[21]. The plasma ascorbate concentration was significantly lower (p<0.001) and decreased ratio of ascorbate: vit E (p<0.0001) in group of NS. Low density lipoprotein was protected for oxidation despite the severe hyperlipidemia and the low circulating Vit C. These data suggest that there may be relative deficit of oxidant/antioxidant balance in NS. This could predispose to increased oxidative stress21. In the present study, mean serum malondialdehyde level was significantly higher in study group II as compared to group I. This result showed the presence of oxidative stress in adult with NS. The decreased total antioxidant status level is connected with abnormal intestine absorption of some antioxidants component in patients with NS. There is some data in the literature showing that a diet deficient in Se and Vit C may lead to renal injury characterized by proteinuria and reduced GFR Bulucu et al.22. Excessive generation of reactive oxygen species is one of the incriminated mechanisms in the pathogenesis of progression renal injury. In fact, the little data is available concerning SOD in NS. Reduced activities of erythrocyte and plasma GSH-Px were reported when compared to the control. Lower Se and erythrocyte Cu-Zn-SOD activity was shown in patients of NS when compared to the control. Erythrocyte and plasma level of malondialdehyde were higher in patients with NS.These results obtained in adult NS patients support the previous data indicating abnormalities in antioxidative system of NS Pawlak K et al.23 During the auto oxidation of Homocysteine in plasma, reactive oxygen species are generated Coppola et al. The latter initiates lipid peroxidation in cell membranes (potentially responsible for endothelial dysfunction) and in circulating lipoprotein, oxidized LDLC may trigger platelet activation as well as some of the homeostatic abnormalities reported in such patients. Thus, the oxidative stress induced by Homocysteine may be a key process in the pathogenesis of thrombosis in Hyperhomocysteinemia24. Several studies have demonstrated that dietary supplementation with folic acid and Vit B12 and Vit B6 is an efficient means to decrease plasma Homocysteine. Endothelial dysfunction may cause proatherogenic effects associated with Hyperhomocysteinemia. Folicacid and Vit B12 deficiencies should be corrected by supplementation in Hyperhomocysteinemia. Increases in folate intake by dietary changes or fortification can also lower plasma. Homocysteine level in NS patients. In renal failure, folic acid treatment (1-5 mg/day) a- meliorate the plasma Homocysteine level in most cases but Hyperhomocysteinemia persists in the majority of patients. Primary (fasting) Hyperhomocysteinemia can be treated with folic acid (0.5-5 mg/day) Sydow et al., Van Guldener et al.25, 26.

 

 

CONCLUSION

We conclude that Hyperhomocysteinemia was related to oxidative stress in NS patients. Long-term follow-up in a large number of patients would be necessary to confirm these results.

 

REFERENCES

  1. Tesar V, Zima T. Recent progress in the pathogenesis of nephrotic proteinuria. Crit Rev Clin Lab Sci. 2008;45(2):139-220.
  2. Ghodake SR, Suryakar AN. Role of reactive oxygen species in pathogenesis of nephrotic syndrome.Indian J Clin Biochem.2010 Jan;25(1):82-5.
  3. Kamireddy R, Kavuri S,Devi S,Vemula H,Chandana D,Harinarayanan S,James R,Rao A. Oxidative stress in pediatric nephrotic syndrome. Clin Chim Acta.2002 Nov;325(1-2):147- 50.
  4. Mishra OP, Gupta AK,Prasad R,Ali Z,Upadhyay RS,Mishra SP,Tiwary NK,Schaefer FS. Antioxidant status of children with idiopathic nephrotic syndrome. PediatrNephrol.2011 Feb;26(2):251-6
  5. Bulucu F,Vural A,Aydin A,Sayal A. Oxidative stress status in adults with nephrotic syndrome. Clin Nephrol.2000 Mar;53(3):169-73.
  6. Ghodake SR,Suryakar AN,Ankush RD,Katkam RV,Shaikh K,Katta AV. Role of free radicals and antioxidant status in childhood nephrotic syndrome.Indian J Nephrol.2011 Jan;21(1):37- 40.
  7. Arnadottir M, Hultberg B,Berg AL. Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy. Nephrol Dial Transplant.2001 Jan;16(1):45-7.
  8. Aminzadeh MA,Gollapudi P,Vaziri ND. Effect of nephrotic syndrome on homocysteine metabolism. Nephrol Dial Transplant. 2011 Apr;26(4):1244-7.
  9. Tkaczyk M,Czupryniak A,Nowicki M,Chwatko G,Bald E. Homocysteine and glutathione metabolism in steroidtreated relapse of idiopathic nephrotic syndrome. Pol Merkur Lekarski.2009 Apr;26(154):294-7.
  10. Koracevic D, Koracevic G, Jordjevic VD et al. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54:356-361.
  11. Hunter MI, Nlemadin BC, Davidson DL. Lipid peroxidation product and antioxidant activity in plasma. Neuroscience 1985; 10:1645-1652.
  12. Roe JH, Kuether CA. The determination of ascorbic acid in the whole blood and urine through the 2,4 dinitrophenylhydrazine derivative of dehydroascorbic acid. J Biol Chem 1943; 147:399-407.
  13. Kaysen GA. Albumin metabolism in the nephrotic syndrome: the effect of dietary protein intake.Am J Kidney Dis.1988 Dec; 12(6):461-80.
  14. Granqvist A,Nilsson UA,Ebefors K, Impaired glomerular and tubular antioxidative defense mechanisms in nephrotic syndrome. Am J Physiol Renal Physiol.2010 Oct;299(4):F898-904.
  15. Candiano G,Musante L,Petretto AET AL. Proteomics of plasma and urine in primary nephrotic syndrome in children.Contrib Nephrol.2008;160:17-28.
  16. Ece A,Atamer Y,Gürkan F. Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome.Pediatr Nephrol.2005 Sep;20(9):1279-84.
  17. Sinha I,Ghosh S,Dey P,Jacob J,Banerjee D. Reduction of urinary thiols in nephrotic syndrome--a possible effect of free iron. Clin Chim Acta.2005 May;355(1-2):91-6.
  18. Majumdar VS, Aru GM, Tyagi SC. Induction of oxidative stress by homocysteine impairs endothelial function. J Cell Biochem 2001; 82(3):491-500.
  19. Gursharan D, Ashley B, Irish GF et al. Homocysteine and nephrotic syndrome. Nephrol Dial Transplant 2001;16:1720-1721
  20. Margret A, Bjorn H, Annalena B. Plasma total homocysteine concentration in nephrotic syndrome patients with idiopathic membranous nephropathy. Nephrol Dial Transplant2001; 16:45-47.
  21. Warwick GL, Waller H, Ferns GA. Antioxidant vitamin concentration and LDL oxidation in nephrotic syndrome. Ann Clin Biochem 2000; 37(pt4):488-491.
  22. Bulucu F, Vural A, Aydin A, Sayal A. Oxidative stress status in adult with nephrotic syndrome. Clin Nephrol 2000; 53: 169-173.
  23. Pawlak K, Pawlak D, Mysliwiec M. Cu/Zn Superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem 2005; 38(8):700-5.
  24. Coppola A, Davi G, De SV et al. Homocysteine, coagulation, platelet function and thrombosis. Semin Thromb Hemost 2000; 26(3):243-254.
  25. Sydow K, Boger RH Homocysteine, endothelial dysfunction and cardiovascular risk: Pathomechanism and therapeutic options. Z. Kardiol 2001; 90(1):1-11.
  26. Van GC, Stehonwer CD. Homocysteine lowering treatment: an overview. Expect opin Pharmacotherapy 2001; 2(9):1449-146.














 








 




 








 

 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.